Differential ChIP-seq peak calling
Differential ChIP-seq peak calling identifies genomic loci where a protein of interest — typically a transcription factor or histone mark — shows significantly altered binding or occupancy between two or more biological conditions. By combining standard ChIP-seq peak detection with count-based statistical testing, the method reveals condition-specific regulatory elements, providing a genome-wide map of dynamic chromatin interactions underlying cellular state changes.
Zdrojový záznam
Citácie skopírované doslovne zo zdrojového záznamu metódy. Nevyplýva z nich žiadne overenie na úrovni tvrdenia.
- Ross-Innes, C. S., Stark, R., Teschendorff, A. E., Holmes, K. A., Ali, H. R., Dunning, M. J., Brown, G. D., Gojis, O., Ellis, I. O., Green, A. R., Ali, S., Chin, S. F., Palmieri, C., Caldas, C., & Carroll, J. S. (2012). Differential oestrogen receptor binding is associated with clinical outcome in breast cancer. Nature, 481(7381), 389-393. · URL
- Stark, R., & Brown, G. (2011). DiffBind: differential binding analysis of ChIP-Seq peak data. Bioconductor Package, Cancer Research UK Cambridge Research Institute. · URL
Spracované tvrdenia
Tvrdenia uložené v registri dôkazov, každé s vlastným hodnotením.
Tento pohľad nevymýšľa hodnotenie tvrdenia, ak register žiadne nemá.
Súvisiace metódy
Vygenerované z grafu metód a zobrazené ako vzťahy navrhnuté strojom – nevyplýva z nich žiadne tvrdenie o dôkaze.